Navigation Links
SemBioSys submits IND for safflower-produced insulin to U.S. FDA
Date:7/29/2008

- Submission demonstrates progress of plant-derived insulin program

scheduled to enter the clinic later this year -

TSX symbol: SBS

CALGARY, July 29 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that it has submitted an Investigational New Drug (IND) application for safflower-produced recombinant human insulin to the United States Food and Drug Administration (FDA). The IND application contains a physical, chemical and structural analysis of safflower-produced insulin to a reference standard, results from 28-day sub-chronic toxicology studies in two species of mammals, demonstration of pharmacodynamic function in animals and describes a cGMP process for the production of safflower-produced insulin. SemBioSys plans to initiate a Phase I/II clinical study of its safflower-produced insulin in the fourth quarter of 2008.

"The submission of the IND is a critical step toward the initiation of a Phase I/II clinical trial with our recombinant human insulin produced from safflower. All of our studies to date confirm that our safflower-produced insulin is equivalent to pharmaceutical-grade human insulin. We met our internal schedule to submit the IND and we are on track to begin human clinical trials in the fourth quarter of 2008 as planned," said Andrew Baum, president and chief executive officer of SemBioSys. "While we intend to initiate our first clinical trial for insulin in the UK, a successful IND application will provide us with the opportunity to consult the FDA on later stage clinical development. We believe this will allow us to apply for European and U.S. approvals for our safflower-produced insulin simultaneously."

SemBioSys also intends to submit a Clinical Trial Application (CTA) to the appropriate European authorities later this quarter. Assuming approval of the CTA, SemBioSys i
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys receives milestone payments from AVAC Ltd.
11. SemBioSys announces first quarter 2008 financial and operational results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The New York investment bank KTA Cap... has agreed an AU$6.7 mil convertible note private... private placement was arranged by KTA Capital as ... New York (PRWEB) November...ank KTA Capital, LLC ("KTA Capital") has...
(Date:11/24/2009)...CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNewswire...oday it is acquiring the assets of Hyland Seeds, a...o. The addition of Hyland Seeds will further expan...company anticipates the introduction of SmartStax...olerant Trait Technology in corn in 2012. The tran...
(Date:11/24/2009)..., ST. LOUIS, Nov. 24 Si...resenting at the NASDAQ OMX conference on Tuesday,.../CST. Interested parties may listen via live audio.../inve s tor.sig m a a ldrich.com/ . Users ... ,, About Sigma-Aldrich: Sigma-Aldrich is ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 /...sdaq: DCGN ) today announced the approval of all o...ourt for the District of Delaware,(the "Bankruptcy...ion for,relief under Chapter 11 of the United Stat..., The orders issued by the Bankruptcy Court a...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...asdaq:,NVAX) today announced that it will report i... release to be issued after 8:00 a.m. Eastern Time... conference call to discuss its,financial results ...l will,be hosted by Novavax President and Chief Ex...s of senior management. A question and answer,sess...
...May 28, 2008 at 8:00 am (Eastern) / 5:0...NGHAI, China, May 6 /Xinhua-PRNewswire/ -- WuXi Ph...rmaceutical, biotechnology and medical device,rese...ations in China and,the United States, today annou...lts for the first quarter 2008 after the US market...
...Supported by a Grant from Otsuka ... May 6 The American Psychiatric,Foundation (APF) ...dividual,as the recipients of the fifth annual APF...awards were presented at the 2008 APF Annual Benef...dual was presented a plaque,along with an award of...
Other Biology Technology:Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call 2WuXi PharmaTech Schedules First Quarter 2008 Earnings Release on Tuesday, May 27, 2008 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 2American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 3American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 4American Psychiatric Foundation Announces Recipients of 2008 Awards for Advancing Minority Mental Health 5
(Date:11/23/2009)...search presents strong evidence that the "synergis... traffic-related pollution and indoor endotoxin ca... other exposure alone. , Environmental health ...llege of Medicine have shown that children exposed...and indoor endotoxin during early life are six tim...
(Date:11/23/2009)... the Wildlife Conservation Society says that weste... Republic of Congopart of the "mother lode" of mor...coming increasingly threatened by growing humans a...otection of the swamp forests adjacent to the sout...ent surveys confirmed that high densities of the g...
(Date:11/23/2009)...he only swine vaccine available for the H1N1 virus...with the virus. The vaccination marks the first ti... with the pandemic flu., Iowa State University,s...ed the vaccine this summer and has been shipping p... and Illinois for several weeks., The latest vac...
Breaking Biology News(10 mins):Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Helix BioPharma Closes Private Placement 13918 1Helix BioPharma Closes Private Placement 13918 2Helix BioPharma Closes Private Placement 13918 3Making connections the key to overcoming shame 56491 1Making connections the key to overcoming shame 56491 2JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 1JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 2JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 3JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 4JDRF funded studies show regular CGM use increases diabetes control for all age groups 9833 5
...tion of an Inuit village already underway, some 40...are convening in Alaska for a UN-affiliated confer...nal knowledge can be used to both mitigate and ada...mpolar Council, the Indigenous Peoples, Global Sum...engthen the communities, participation in and arti...
...warmer from 18,700 to 10,000 years ago, juniper tr...obbing packrats of their favorite food. Now, Unive...r detoxification genes that let the rodents eat to... was either eat it or move out," says biology Prof...published online Tuesday, April 7 in the journal ...
... cancer, one of the most fatal cancers, due to the...ffective therapies: Johns Hopkins University patho... growth factor receptor aberrantly active in appro...rs studied. , In a presentation April 18, at E...y explained why this finding and related work in h...
Other Biology News:Indigenous peoples at world summit to share climate change observations, coping techniques 2Indigenous peoples at world summit to share climate change observations, coping techniques 3Indigenous peoples at world summit to share climate change observations, coping techniques 4Indigenous peoples at world summit to share climate change observations, coping techniques 5Indigenous peoples at world summit to share climate change observations, coping techniques 6Poison: It's what's for dinner 2Poison: It's what's for dinner 3Poison: It's what's for dinner 4Poison: It's what's for dinner 5Newly discovered epidermal growth factor receptor active in human pancreatic cancers 2
...rade; SAPK/JNK (Thr183/Tyr185) Antibody Kit Kit I...dy, Catalog #9251, 200 ul SAPK/JNK (56G8) Rabbit m...Catalog #9253, (4 Western mini-blots) Anti-rabbit ...ti-biotin IgG, HRP-linked Antibody, Catalog #7075,...
Duck Anti-Phenytoin-BSA Antibody, Unconjugated from Good Biotech Corp
Rabbit Anti-GPCR TM7XN1 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-MEF2A, phospho (Thr312) Antibody, Unconjugated from Spring Bioscience
Biology Products: